# NovoLog Mix 70/30

NDC: 0169-2201
Generic name: insulin aspart
Labeler / Manufacturer: Novo Nordisk
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SUSPENSION
Routes: SUBCUTANEOUS
Marketing started: 20020911

FDA application: BLA021172

## Active ingredients

- INSULIN ASPART: 100 [iU]/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0169-2201"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0169-2201
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=1861fcee-7673-4afe-a206-08fa05c0add2